SCHEMBL9904107

SCHEMBL9904107

Cn1c(=O)c2[nH]c(-n3cc(-c4ccc(CO)cc4)nn3)nc2n(C)c1=O

nearest known ligand 0.49

Predicted protein targets (top 18)

geneUniProtsupporting neighboursconfidence
ADORA2B P29275 6/20 0.46
ADORA2A P29274 4/20 0.46
ALOX15 P16050 1/20 0.44
ADORA1 P30542 3/20 0.43
KDM4E B2RXH2 2/20 0.43
ADORA3 P0DMS8 2/20 0.43
HSD17B10 Q99714 2/20 0.43
ALDH1A1 P00352 1/20 0.43
GLA P06280 1/20 0.43
HPGD P15428 1/20 0.43
NFKB1 P19838 1/20 0.43
CYP2C19 P33261 1/20 0.43
DCTPP1 Q9H773 1/20 0.42
CYP1A2 P05177 1/20 0.42
BLM P54132 1/20 0.42
NPSR1 Q6W5P4 1/20 0.42
MEN1 O00255 1/20 0.42
KMT2A Q03164 1/20 0.42

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL9904126 0.86 DCTPP1 (0.56) ADORA2BADORA2AADORA1KDM4EADORA3
SCHEMBL9928556 0.84 ADORA2B (0.61) ADORA2BADORA2AKDM4EALDH1A1CYP1A2
SCHEMBL9904014 0.83 PTGS2 (0.45) ADORA2BADORA2AADORA1KDM4EADORA3
SCHEMBL9904115 0.82 KDM4E (0.47) ADORA2BADORA2AALOX15ADORA1KDM4E
SCHEMBL9904155 0.81 ADORA2B (0.48) ADORA2BADORA2AADORA1KDM4EADORA3
SCHEMBL9904008 0.80 MAPT (0.57) ADORA2BADORA2AADORA1KDM4EADORA3
SCHEMBL9928558 0.80 ADORA2A (0.43) ADORA2BADORA2AADORA1KDM4EADORA3
SCHEMBL9943454 0.80 ALDH1A1 (0.64) ADORA2BADORA2AADORA1KDM4EADORA3
SCHEMBL9904037 0.79 MAOA (0.47) ADORA2BADORA2AALDH1A1KMT2A
SCHEMBL9904312 0.78 ADORA2B (0.48) ADORA2BADORA2AADORA1KDM4EADORA3

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-2465859-A1 8-Triazolylxanthine derivatives, processes for their production and their use as adenosine receptor antagonists Life & Brain GmbH (DE) 2012-06-20 EP disclosed
WO-2012076974-A1 8-TRIAZOLYLXANTHINE DERIVATIVES, PROCESSES FOR THEIR PRODUCTION AND THEIR USE AS ADENOSINE RECEPTOR ANTAGONISTS LIFE & BRAIN GMBH (DE) 2012-06-14 WO disclosed